Venture Capital Arm of
39 Investments in 26 Companies
London, England
Venture Capital
REV (formerly Reed Elsevier Ventures) is a financially focused corporate VC backed by RELX Group

Investor Details


REV is a global venture capital partnership. We are backed by one of the world's largest content, technology and analytics companies, RELX Group. Our mission is to help build companies that can transform their markets through the application of data, technology and analytics. Since 2000 we have invested over $200m in Big Data, Digital Health, Internet and Enterprise Technology companies. We have been early investors in disruptive category leaders like Palantir, Healthline, Babbel and Netli. Their portfolio of companies is part of a large, extended family of businesses that also includes the entire Reed Elsevier Group. Collaboration is actively encouraged and supported. Their focus is high growth, internet, media & technology businesses based in the US, Europe or Israel. Their typical sectors include: new media, mobile, big data & analytics, healthcare information & software and groundbreaking analytic technologies. They will invest at any stage of a company's development, from early/seed stage to growth capital and whatever their initial capital investment, they remain committed to helping the company achieve market leadership. We are a global investor active in all the major western venture capital hubs - San Francisco, New York, Boston, Los Angeles, Seattle, London, Berlin and Tel Aviv. Our largest portfolio cluster is in California.

DateInvested InRoundPartner(s)
Apr, 2016$36M / Series C (Lead)
Nov, 2015$50M / Series C
Jul, 2015$22M / Series C
May, 2015$6M / Series C
Apr, 2015$12M / Series D (Lead)
Mar, 2015$1.8M / Seed
Nov, 2014$8M / Series A (Lead)
Aug, 2014$6M / Series C (Lead)
Jun, 2014$10.85M / Series B
May, 2014$3.82M / Venture (Lead)
Feb, 2014$8M / Series F
Jan, 2014$21M / Series B
Aug, 2013$14M / Series D (Lead)
Jun, 2013$5M / Series B
May, 2013$3.9M / Series B
Apr, 2013$14.5M / Series B
Mar, 2013$10M / Series B (Lead)
Nov, 2012$10M / Series B (Lead) and
Apr, 2012$8.5M / Series A
Dec, 2011$13M / Venture
Sep, 2011€2M / Venture
May, 2011$6M / Series E (Lead)
May, 2011$1.5M / Series A (Lead)
Apr, 2011$1.4M / Venture
Aug, 2010$1.1M / Seed
Jun, 2010$6.29M / Series B (Lead)
Apr, 2010$14M / Series C
Dec, 2009undisclosed amount / Seed
Dec, 2009$4.5M / Series A (Lead)
Apr, 2008$7M / Series D
Feb, 2008$36.75M / Series C
Jan, 2008$25M / Series E
Nov, 2006$10.52M / Series B
Jul, 2006$18M / Series C
Feb, 2006$18M / Venture
Feb, 2006$12.4M / Series C
Jun, 2004$7M / Series C (Lead)
Oct, 2002$22M / Series D
Dec, 2001$33M / Venture (Lead) and

Current Team (3)


Offices/Locations (1)

  • London Office

    1-3 Strand

    London, England WC2N 5JR

    United Kingdom

Images (1)


Add Board Members and Advisors

Add Funds

Add Competitors

Add Memberships

Add Videos